Health Outcomes & Pharmacy Practice


Photo of Crismon

Crismon, Lynn, Pharm.D., FCCP, BCCP
James T. Doluisio Regents Chair
& Behrens Inc. Centennial Professor
of Health Outcomes & Pharmacy Practice
PHR 5.112G
512- 471-3718

Selected Publications

Schur SB, Sikich L, Findling RL; Malone RP, Crismon ML , Derivan, A, MacIntyre II JC, Pappadopulos E, Greenhill L, Schooler N, Van Orden K, Jensen PS. Treatments for aggression in children and adolescents: a review. Journal of the American Academy of Child & Adolescent Psychiatry 2003;42:132-44.

Pappadopulos E, MacIntyre JC, Crismon ML , Findling RL, Malone RP, Derivan A, Schooler N, Sikich L, Greenhill L, Schur SB, Felton C, Kanzler H, Rube D, Sverd J, Finnerty M, Ketner S, Siennick SE, Jensen PS. Treatment recommendations for the use of antipsychotics for aggressive Youth (TRAAY): Part II. Journal of the American Academy of Child & Adolescent Psychiatry 2003;42:145-61.

*Cala S, Crismon ML , *Baumgartner JL. A survey of herbal medicines in children with ADHD or depressive disorders. Pharmacotherapy 2003;23:222-30.

Pliszka SR, Lopez M, Crismon ML , Toprac M, Hughes CW, Emslie GJ, Boemer C. A feasibility study of the Children's Medication Algorithm Project (CMAP) algorithm for the treatment of ADHD. Journal of the American Academy of Child & Adolescent Psychiatry 2003;42:279-87.

Kashner TM, Carmody TJ, Suppes T, Rush AJ, Crismon ML , Miller AL, Toprac M, Trivedi M. Catching-up on health outcomes: The Texas Medication Algorithm Project. Health Services Research 2003;38:311-31.

Rush AJ, Crismon ML , Kashner TM, Toprac MG, Carmody TJ, Trivedi MH, Suppes T, Miller AL, Biggs MM, Shores-Wilson K, Witte B, Shon SP, Rago WV, Altshuler KZ. Texas Medication Algorithm Project ' Phase III (TMAP-III): rationale and design. Journal of Clinical Psychiatry 2003;64:357-69.

Suppes T, Dennehy E, Rush AJ, Crismon ML , Kashner, TM, Carmody TJ, Toprac MG, Biggs MM, Shores-Wilson K, Witte B, Trivedi MH, Steven SP. Texas Medication Algorithm Project: clinical results for patients with a history of mania. Journal of Clinical Psychiatry 2003;64:370-82.

Crismon ML , *DeLeon A, Miller AL. Aripiprazole: Does partial dopaminergic agonism translate into clinical benefits? Annals of Pharmacotherapy 2003;37:738-40.

Defilippi J, Crismon ML . Drug interactions with cholinesterase inhibitors. Drugs Aging 2003;20:437-44.

Rascati KL, Johnsrud MT, Crismon ML , Lage MJ, Barber BL. Olanzapine versus risperidone in the treatment of schizophrenia: A comparison of costs among Texas Medicaid patients. Pharmacoeconomics 2003;21;683-97.

*Chuang WC, Crismon ML . Evaluation of a schizophrenia medication algorithm in a state hospital. American Journal of Health-System Pharmacy 2003;60:1459-67.

*Hartnell NR, Wilson JP, *Patel NC, Crismon ML . Patterns associated with selective serotonin reuptake inhibitor spontaneous adverse event reporting. Annals of Pharmacotherapy 2003;37:1387-91.

Baker CB, Johnsrud MT, Crismon ML , Rosenheck RM, Woods SW. Quantitative analysis of sponsorship bias in economic studies of antidepressants. British Journal of Psychiatry 2003;183:498-506.

Dewan NA, Conley D, Svendsen D, Shon SP, Staup JR, Miller AL, Crismon ML , Rush AJ, Trivedi M, Skale T, Keck PE, Strawkowski SM. A quality improvement process for implementing the Texas Algorithm for schizophrenia in Ohio. Psychiatric Services 2003;54:1646-49.

Finley PR, Crismon ML , Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy 2003;23:1634-44.

Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML , Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychological Medicine 2004;34:73-82.

Dennehy EB, Suppes T, Rush AJ, Crismon ML , Witte B, Webster J. Development of a computerized assessment of clinician adherence to a treatment guideline for patients with bipolar disorder. Journal of Psychiatric Research 2004;38:285-94.

Emslie GJ, Hughes CW, Crismon ML , Lopez M, Pliszka S, Toprac MG, Boemer C. A feasibility study of the childhood depression medication algorithm: the Texas Children's Medication Algorithm Project (CMAP). Journal of the American Academy of Child & Adolescent Psychiatry 2004;43:519-27.

Miller AL, Hall CS, Buchanan RW, Buckley PF, Chiles J, Conley RR, Crismon ML , Ereshefsky L, Essock SM, Finnerty M, Marder SR, Miller D, McEvoy J, Rush AJ, Saeed SA, Schooler NR, Shon S, Stroup S, Tarin-Godoy B. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 Update. Journal of Clinical   Psychiatry 2004;65:500-8.

*Bettinger TL, Crismon ML , Trivedi MH, Grannemann B, Shon SP. Clinician adherence to an algorithm for depression in the Texas public mental health sector. Psychiatric Services 2004;55:703-5.

*De Leon A, *Patel NC, Crismon ML . Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability. Clinical Therapeutics 2004;26:649-66.

Rush AJ, Trivedi M, Carmody TJ, Biggs MM, Shores-Wilson K, Ibrahim H, Crismon ML . One year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies. Biological Psychiatry 2004;56:46-53.

Trivedi MH, Rush AJ, Crismon ML , Kashner, TM, Toprac MG, Carmody TJ, Key T, Biggs MM, Shores-Wilson K, Witte B, Suppes, Miller AL, Steven SP. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project:. Archives of General Psychiatry 2004;61:669-80.

*Patel NC, *Kistler JL, *James EB, Crismon ML . A retrospective analysis of olanzapine and quetiapine on weight and body mass index in children and adolescents. Pharmacotherapy 2004;24:824-30.

Dennehy EB, Suppes T, Crismon ML , Toprac M, Carmody TJ, Rush AJ. Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder. Psychiatry Research 2004;127:137-45.

Velligan DI, DiCocco M, Bow-Thomas C, Cadle C, Glahn DC, Miller AL, Biggs MM, Shores-Wilson K, McKenzie CA, Crismon ML . A brief cognitive assessment (BCA) for use with schizophrenia patients in a community clinic. Schizophrenia Research 2004;71:273-83.

Miller AL, Crismon ML , Rush AJ, Chiles J, Kashner M, Toprac M, Carmody T, Biggs M, Shores-Wilson K, Chiles J, Witte B, Bow-Thomas C, Velligan DI, Trivedi M, Suppes T, Shon S. The Texas Medication Algorithm Project: clinical results for schizophrenia. Schizophrenia Bulletin 2004;30:627-47.

Crismon ML , Canales PL. Insomnia. In: Berardi RR, McDermott JH, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ. eds. Handbook of nonprescription drugs, 14th ed. Washington, D.C.: American Pharmaceutical Association, 2004:1117-32.

Miller AL, Crismon ML , Hall CS, Baker CB. Advances in psychopharmacology and pharmacoeconomics. In: Levin B, Petrila J, (eds.) Mental health services: a public health perspective, 2nd ed. New York: Oxford University Press, 2004:344-70.

Lopez MA, Toprac MG, Crismon ML , Boemer C, *Baumgartner J, Peyson R, Sheldon S. A psychoeducational program for children with ADHD or depression and their families: results from the CMAP feasibility study. Community Mental Health Journal 2005;41:51-66.

*Patel NC, Crismon ML , Hoagwood K, Jensen PS.   Unanswered questions regarding antipsychotic use in aggressive children and adolescents.   Journal of Child & Adolescent Psychopharmacology 2005;15:270-284.

*Patel NC, Crismon ML , Hoagwood K, Johnsrud MT, Rascati KL, Wilson JP, Jensen PS. Trends in the use of typical and atypical antipsychotics in children and adolescents. Journal of the American Academy of Child & Adolescent Psychiatry 2005;44:548-556.

*Sanchez RJ, Crismon ML , Barner JC, Bettinger T, Wilson JP.   Assessment of adherence measures with different psychostimulants among children and adolescents.   Pharmacotherapy   2005;25:909-917.

Velligan DI, Prihoda TJ, Dennehy EB, Biggs MM, Shores-Wilson K, Crismon ML , Rush AJ, Miller AL, Suppes T, Trivedi M, Kashner TM, Witte BS, Toprac M, Carmody T, Chiles J, Shon S.   The Brief Psychiatric Rating Scale Expanded Version:   How do new items affect factor structure?   Psychiatry Research   2005;135:217-228.

Suppes T, Dennehy E, Hirschfeld RMA, Altshuler LL, Bowden CL, CaliÃ…Lbrese CR, Crismon ML , Ketter T, Sachs G, Swann AC.   The Texas implementation of medication algorithms:   Update to the algorithms for treatment of bipolar I disorder.   Journal of Clinical Psychiatry 2005;60:870-886.

*Patel NC, Crismon ML , Miller AL Johnsrud MT.   Drug adherence: Effects of decreased visit frequency on adherence to clozapine therapy.   Pharmacotherapy   2005;25:1242-1247.

*Hunziker ME, *Suehs BT, Bettinger T, Crismon ML .   Duloxetine: A new dual-acting antidepressant medication for the treatment of major depressive disorder.   Clinical Therapeutics   2005;27:1126-1143.

Dennehy EB, Suppes T, Rush AJ, Miller AL, Trivedi MH, Crismon ML , Carmody TJ, Kashner TM.   Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder?   Results from the Texas Medication Algorithm Project.   Psychological Medicine   2005;29:1-12.

*Patel NC, Crismon ML , *Pondrom M.   Rehospitalization rates of patients with bipolar disorder discharged on a mood stabilizer versus a mood stabilizer plus an atypical or typical antipsychotic.   Journal of Behavioral Health Services Research   2005;32:438-445.

Johnsrud M, Crismon ML , Thompson A, Grogg A.   A n economic comparison of risperidone and olanzapine use within an integrated managed mental health program.   Administrative Policy & Mental Health   2005; Oct 20: 1-7.

Crismon ML , Buckley PF.   Schizophrenia.   In:   DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds.   Pharmacotherapy:   a pathophysiologic approach, 6th ed .   New York, NY, McGraw Hill, 2005:1209-1233.

Adair M, Burkett J, Crismon ML, Logan L, Lopez M, Muse N, Muzquiz-Drummond S, Pliszka S, Robinsion V, Shon S.   Psychotropic medication utilization parameters for foster children.   Austin, TX:   Texas Department of State Health Services, 2005. 9 pps.

Bettinger T, Crismon ML .   Lithium.   In: Burton ME, Shaw LM, Schentag JJ, Evans WE.   (eds).   Applied pharmacokinetic & pharmacodynamics: Principles of therapeutic drug monitoring, 4 th ed.   Baltimore: Lippincott Williams & Wilkins, 2006:798-812.

*Patel NC, Crismon ML , Hoagwood K, Johnsrud MT, Rascati KL, Wilson JP.   Physician specialty associated with antipsychotic prescribing for youths in Texas Medicaid.   Medical Care   (in press).

*Patel NC, Crismon ML , Shafer A, *DeLeon A, Lopez M, *Lane DC.   Ethnic variation in symptoms and response to risperidone in youths with schizophrenia-spectrum disorders.   Social Psychiatry and Psychiatric Epidemiology   (in press).

Kashner TK, Rush AJ, Crismon ML , Toprac M, Carmody TJ, Kashner TM, Miller AL, Trivedi M, Wicker A, Suppes T.   Cost-outcome in the Texas medication algorithm project: an empirical analysis.   Psychiatric Services   (in press).

*Patel NC, Crismon ML , Shafer A.   Evaluation of diagnoses among youths receiving antipsychotic treatment and mental health services in a public mental health system.   Annals of Pharmacotherapy   (in press).

Rush AJ, Ibrahim H, Biggs MM, Shores-Wilson M, Trivedi MH, Carmody TJ, Toprac M, Crismon ML .   Do the 30-item and the Quick (16-item) Inventories of Depressive Symptomatology Self-report Ratings in Public Sector Patients Compare Favorably to Clinician Ratings?   Psychiatric Services   (in press)

*indicates that the author was a student or trainee working under supervision

More information about Dr. Crismon
> Education & Board Certifications
> Return to Dr. Crismon's Home Page

Last Reviewed: June 15, 2009

Division Information

Mailing Address:
Pharmacy Practice
The University of Texas
at Austin
2409 University Ave.
Stop A1900
Austin, TX, USA

Email Address: pharmacy


Young Cited for Regents Teaching Honor

Dr. Veronica Young is the recipient of a 2014 Regents' Outstanding Teaching Award from The University of Texas at Austin.
>Read more about this honor.

Barner Cited for Top Teaching Award

Dr. Jamie Barner was named as the recipient of the Educator of the Year at the first College of Pharmacy Teaching Awards Ceremony and Reception.
>Read more about this honor.

Brown Named APhA Fellow

Dr. Carolyn Brown, professor of health outcomes and pharmacy practice, has been named an APhA fellow.
>Read more about this honor.

index of the major headings: a b c d e f g h i j k l m n o p q r s t u v w x y z